| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |